DK574482A - Fremgangsmaade til fremstilling af radionuclid-maerkede proteiner, navnlig antistoffer eller antistof-fragmenter, radiofarmaceutisk komposition indeholdende disse proteiner, samt et radiodiagnostisk udstyr - Google Patents

Fremgangsmaade til fremstilling af radionuclid-maerkede proteiner, navnlig antistoffer eller antistof-fragmenter, radiofarmaceutisk komposition indeholdende disse proteiner, samt et radiodiagnostisk udstyr Download PDF

Info

Publication number
DK574482A
DK574482A DK574482A DK574482A DK574482A DK 574482 A DK574482 A DK 574482A DK 574482 A DK574482 A DK 574482A DK 574482 A DK574482 A DK 574482A DK 574482 A DK574482 A DK 574482A
Authority
DK
Denmark
Prior art keywords
proteins
acid
antibody fragments
radiody
radionuclid
Prior art date
Application number
DK574482A
Other languages
Danish (da)
English (en)
Inventor
Wilhelmus Theodorus Goedemans
Original Assignee
Byk Mallinckrodt Cil Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19838626&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK574482(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Mallinckrodt Cil Bv filed Critical Byk Mallinckrodt Cil Bv
Publication of DK574482A publication Critical patent/DK574482A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK574482A 1981-12-29 1982-12-27 Fremgangsmaade til fremstilling af radionuclid-maerkede proteiner, navnlig antistoffer eller antistof-fragmenter, radiofarmaceutisk komposition indeholdende disse proteiner, samt et radiodiagnostisk udstyr DK574482A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8105880 1981-12-29

Publications (1)

Publication Number Publication Date
DK574482A true DK574482A (da) 1983-06-30

Family

ID=19838626

Family Applications (1)

Application Number Title Priority Date Filing Date
DK574482A DK574482A (da) 1981-12-29 1982-12-27 Fremgangsmaade til fremstilling af radionuclid-maerkede proteiner, navnlig antistoffer eller antistof-fragmenter, radiofarmaceutisk komposition indeholdende disse proteiner, samt et radiodiagnostisk udstyr

Country Status (7)

Country Link
EP (1) EP0083129B1 (de)
JP (1) JPS58126817A (de)
AT (1) ATE17825T1 (de)
AU (1) AU562619B2 (de)
CA (1) CA1222691A (de)
DE (1) DE3269028D1 (de)
DK (1) DK574482A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443426A (en) * 1982-06-14 1984-04-17 Yale University Blood agent
CA1223831A (en) * 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
AU580958B2 (en) * 1983-07-07 1989-02-09 Mallinckrodt, Inc. Sterile radioactive indium-containing aqueous solution
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US4897254A (en) * 1984-09-21 1990-01-30 The Dow Chemical Company Radioactive compositions for the treatment of calcific tumors
EP0176288B1 (de) * 1984-09-21 1990-05-09 The Dow Chemical Company Aminocarbonsäurekomplexe zur Behandlung von Knochentumoren
EP0210684A1 (de) * 1985-07-31 1987-02-04 MALLINCKRODT, INC.(a Missouri corporation) Ein eine radioaktive Metallzusammensetzung enthaltendes Präparat für Radiodiagnostika
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5021567A (en) * 1987-09-24 1991-06-04 Abbott Laboratories 8-hydroxyquinoline chelating agents
US5245026A (en) * 1987-09-24 1993-09-14 Abbott Laboratories Metal containing 8-hydroxyquinoline chelating agents
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
PT590766E (pt) * 1992-07-31 2000-07-31 Australian Nuclear Science Tec Complexos metalicos de hidroxiarilo contendo agentes quelantes de acido aminocarboxilico
EP0709100A1 (de) * 1994-09-30 1996-05-01 Nihon Medi-Physics Co., Ltd. Kontrastmittel mit mehreren Detektionsgruppen pro Molekül
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US7993626B2 (en) * 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition
JPS56125317A (en) * 1980-03-08 1981-10-01 Nippon Mejifuijitsukusu Kk Stable radioactive diagnosticum with radioactive metallic mark
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same

Also Published As

Publication number Publication date
JPS58126817A (ja) 1983-07-28
ATE17825T1 (de) 1986-02-15
DE3269028D1 (en) 1986-03-20
EP0083129A1 (de) 1983-07-06
EP0083129B1 (de) 1986-02-05
AU9151082A (en) 1983-07-07
CA1222691A (en) 1987-06-09
AU562619B2 (en) 1987-06-18

Similar Documents

Publication Publication Date Title
DK574482A (da) Fremgangsmaade til fremstilling af radionuclid-maerkede proteiner, navnlig antistoffer eller antistof-fragmenter, radiofarmaceutisk komposition indeholdende disse proteiner, samt et radiodiagnostisk udstyr
Butkowski et al. Primary Structure of Human Prethrombin 2 and cw-Thrombin
US4668503A (en) Process for labeling amines with 99m Tc
US5078985A (en) Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
McFarlane Efficient trace-labelling of proteins with iodine
US5514363A (en) Method for radiolabeling antibody fragments
CA2065299C (en) Direct radiolabeling of antibodies and other proteins with technetium or rhenium
JP2769244B2 (ja) 蛋白質のテクネチウム／レニウム標識方法
Kuby et al. Studies on adenosine triphosphate transphosphorylases. Amino acid sequence of rabbit muscle ATP-AMP transphosphorylase
Chance Amino acid sequences of proinsulins and intermediates
US5334708A (en) Method for radiolabeling monovalent antibody fragments
Sammon et al. Metabolism of Labeled Parathyroid Hormone. I. Preparation of Biologically Active 125I-Labeled Parathyroid Hormone1
DE3889851D1 (de) Verfahren und Materialien zur Herstellung der Lösungen von metallmarkierten Antikörpern.
Neuman et al. The metabolism of labeled parathyroid hormone: II. Methodological studies
EP0412012A1 (de) Technetium-99m-markierte Polypeptide und ihre Anwendungen in der Bilderzeugung
Tabachnick et al. Thyroxine-protein interactions: II. The binding of thyroxine and its analogues to human serum albumin
Chervu et al. Radiolabeling of antigens: Procedures andassessment of properties
Chersi et al. Isolation, chemical and immunologic characterization of κ-and λ-type light chains from IgG of normal rabbits with b9 allotype
McKenzie et al. Alternate Positions for the Sulphydryl Group in β-Lactoglobulin: the Significance for Sulphydryl Location in Other Proteins
ATE15109T1 (de) Verfahren zur herstellung einer chromogenen reaktionsmischung zur bestimmung der eisenkonzentration und -bindungskapazitaet von serum sowie die dabei erhaltene chromogene reaktionsmischung.
Eshkol Labelling of antigens by various isotopes
CN117241840A (zh) 放射性医药组合物的中间体的保存方法、放射性医药组合物的制备或保存方法、放射性医药组合物的中间体组合物、及医药制剂
JP3549115B2 (ja) テクネチウム−９９ｍで標識された臓器特異的物質の製造方法
Hughes The chemical requirements of a satisfactory label for proteins
Harrison Indium chemistry in radiopharmaceutical development

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment